Wintac (Delisted) share news and announcements

BSE: 524758

Last traded ₹341.60 on 17 Dec 2020

Delisted on 28 Dec 2020.

Wintac share news and announcements

338 announcements, routine notices left out, newest first. Page 7 of 7.

Jun 2012
- 4 Jun · Results
  Financial Results & a copy of the Auditors' Report for the period ended March 31, 2012. (opens in a new tab)
May 2012
- 8 May · Disclosure
  S Jayaprakash Mady has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Apr 2012
- 2 Apr · Disclosure
  S Jayaprakash Mady has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE: (opens in a new tab)
Mar 2012
- 22 Mar · Disclosure
  Promoters have further created pledge and also vacated pledge. (For more details kindly refer www.bseindia.com) (opens in a new tab)
Feb 2012
- 18 Feb · Limited Review for Dec 31, 2011
  Limited Review Report for the period ended December 31, 2011. (opens in a new tab)
- 9 Feb · Results
  Financial Results for the period ended December 31, 2011. (opens in a new tab)
Jan 2012
- 3 Jan · Disclosure
  S T Raghavendra Mady has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE. (opens in a new tab)
- 3 Jan · Disclosure
  Bangalore Pharmaceuticals & Research Laboratory Pvt Ltd (Acquirer) has submitted the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE: (opens in a new tab)
- 2 Jan · Disclosure
  Bangalore Pharmaceutical & Research Laboratory (P) Ltd has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Dec 2011
- 27 Dec · Business
  Bangalore Pharmaceuticals & Research Laboratory Pvt Ltd has submitted the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition .... (opens in a new tab)
Nov 2011
- 22 Nov · Limited Review for the quarter ended Sep 30, 2011
  Auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2011. (opens in a new tab)
- 15 Nov · Results
  Financial Results for the period ended September 30, 2011. (opens in a new tab)
Sep 2011
- 28 Sep · Meeting
  Members at the 21st Annual General Meeting (AGM) of the Company held on September 26, 2011, inter alia, have accorded to the following: 1. Adoption .... (opens in a new tab)
Aug 2011
- 31 Aug · Limited Review for the quarter ended June 30, 2011
  Auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2011. (opens in a new tab)
- 30 Aug · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2011 to September 26, 2011 (both days inclusive) for ....
- 18 Aug · Disclosure
  Promoter have partially vacated pledge on the shareholdings.(For more details kindly refer www.bseindia.com) (opens in a new tab)
- 17 Aug · Results
  Financial Results for the Period ended June 30, 2011. (opens in a new tab)
Jul 2011
- 27 Jul · Disclosure
  S T Raghavendra Mady has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE (opens in a new tab)
Jun 2011
- 21 Jun · Disclosure
  Promoters have further pledged 3,50,000 shares of Rs. 10/- each as per the details given below: Name of the promoter : Kripa Mady No. of .... (opens in a new tab)
- 6 Jun · Limited Review for the quarter ended March 31, 2011
  Auditor's have conducted the limited review of the unaudited financial results for the quarter ended March 31, 2011. (opens in a new tab)
May 2011
- 18 May · Corporate action
  May 27, 2011 has been fixed as Record Date for the purpose of considering the Rights Entitlement of Members for the proposed rights issue of equity shares ....
- 9 May · Results
  Financial Results for the period ended March 31, 2011. (opens in a new tab)
Feb 2011
- 3 Feb · Results
  Financial Results for the Quarter ended December 31, 2010. (opens in a new tab)
Nov 2010
- 23 Nov · Limited Review for the quarter ended Sep 30, 2010
  Auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2010. (opens in a new tab)
Oct 2010
- 30 Oct · Results
  Financial Results for the Quarter ended September 30, 2010.
Sep 2010
- 14 Sep · Meeting
  Members at the 20th Annual General Meeting (AGM) of the Company held on September 09, 2010, inter alia, have accorded to the following: 1. Adoption .... (opens in a new tab)
Aug 2010
- 26 Aug · Management
  Sri. H. R. Kedlaya, Non-Executive and Independent Director of the Company has resigned as Director of the Company owning to his poor health conditions. ....
- 26 Aug · Board meeting
  Board of Directors of the Company at its meeting held on August 26, 2010 has decided to revise the price of Rights Issue of equity shares from Rs. 30/- ....
- 17 Aug · Disclosure
  Wintac Ltd has submitted the disclosure under Regulation 8A of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE(For more details kindly refer www.bseindia.com) (opens in a new tab)
- 10 Aug · Results
  Financial Results for the Quarter ended June 30, 2010. (opens in a new tab)
May 2010
- 4 May · Results
  Financial Results for the Quarter & Year ended March 31, 2010. (opens in a new tab)
Apr 2010
- 26 Apr · Meeting
  Members at the Extra Ordinary General Meeting (EGM) of the Company held on April 22, 2010, inter alia, have accorded to the following: 1. Increase .... (opens in a new tab)
- 23 Apr · Updates
  Company has received formal approval for the ANDA from US FDA authorities for Ondansetron Hydrochloride 20ml Injection.
- 1 Apr · Meeting
  Extra Ordinary General Meeting (EGM) of the members of the Company will be held on April 22, 2010, inter alia, to transact the following business: .... (opens in a new tab)
Mar 2010
- 18 Mar · Corporate action
  Board of Directors of the Company at its meeting held on March 18, 2010, has decided to issue further 22,75,000 equity shares on rights basis to the ....
- 17 Mar · Limited Review for the quarter ended Dec 31, 2009
  Auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2009. (opens in a new tab)
- 10 Mar · Board meeting
  Meeting of the Board of Directors of the Company will be held on March 18, 2010, inter alia, to consider, the issue of equity shares on rights issue basis ....
Jan 2010
- 30 Jan · Results
  Financial Results for the Quarter ended December 31, 2009. (opens in a new tab)